ENTITY

CF PharmTech (2652 HK)

4
Analysis
Health Care • China
CF PharmTech is a specialty pharmaceutical company focused on the research, development, manufacturing, and commercialization of inhalation technologies and respiratory drugs. The company specializes in treatments for asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis, with key products including budesonide suspension for inhalation and azelastine hydrochloride and fluticasone propionate nasal spray. Headquartered in Suzhou, China, the company was founded in 2007.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x